http://www.unboundmedicine.com/medline/ebm/research/tacrolimus__oral__IV_Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19917375/full_citation/Electrolyte_Free_Water_Clearance_Could_Be_an_Early_Sign_of_Renal_Dysfunction_in_Renal_Transplant_Patients_Tekgündüz E, Apaydın S, Seyahi N, et al. 
Electrolyte Free Water Clearance Could Be an Early Sign of Renal Dysfunction in Renal Transplant Patients. [JOURNAL ARTICLE]
Transplant Proc 2009 Nov; 41(9):3726-3730.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19835971/full_citation/An_Age_Dependent_Pharmacokinetic_Study_of_Intravenous_and_Oral_Mycophenolate_Mofetil_in_Combination_with_Tacrolimus_for_GVHD_Prophylaxis_in_Pediatric_Allogeneic_Stem_Cell_Transplantation_Recipients_Bhatia M, Militano O, Jin Z, et al. 
An Age Dependent Pharmacokinetic Study of Intravenous and Oral Mycophenolate Mofetil in Combination with Tacrolimus for GVHD Prophylaxis in Pediatric Allogeneic Stem Cell Transplantation Recipients. [JOURNAL ARTICLE]
Biol Blood Marrow Transplant 2009 Oct 13.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19589481/full_citation/Graft_versus_host_disease_prophylaxis_with_tacrolimus_and_mycophenolate_mofetil_in_HLA_matched_nonmyeloablative_transplant_recipients_is_associated_with_very_low_incidence_of_GVHD_and_nonrelapse_mortality_Sabry W, Le Blanc R, Labbé AC, et al. 
Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality. [Journal Article, Research Support, Non-U.S. Gov't]
Biol Blood Marrow Transplant 2009 Aug; 15(8):919-29.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19539216/full_citation/Comparison_of_Tacrolimus_and_Sirolimus__Tac/Sir__versus_Tacrolimus_Sirolimus_and_Mini_Methotrexate__Tac/Sir/MTX__as_Acute_Graft_versus_Host_Disease_Prophylaxis_after_Reduced_Intensity_Conditioning_Allogeneic_Peripheral_Blood_Stem_Cell_Transplantation_Ho VT, Aldridge J, Kim HT, et al. 
Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and Mini-Methotrexate (Tac/Sir/MTX) as Acute Graft-versus-Host Disease Prophylaxis after Reduced-Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation. [Journal Article]
Biol Blood Marrow Transplant 2009 Jul; 15(7):844-50.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19531982/full_citation/Population_Pharmacokinetics_of_Tacrolimus_in_Pediatric_Hematopoietic_Stem_Cell_Transplant_Recipients:_New_Initial_Dosage_Suggestions_and_a_Model_Based_Dosage_Adjustment_Tool_Wallin JE, Friberg LE, Fasth A, et al. 
Population Pharmacokinetics of Tacrolimus in Pediatric Hematopoietic Stem Cell Transplant Recipients: New Initial Dosage Suggestions and a Model-Based Dosage Adjustment Tool. [JOURNAL ARTICLE]
Ther Drug Monit 2009 Jun 11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18798361/full_citation/Umbilical_cord_blood_transplantations_from_unrelated_donors_in_patients_with_inherited_metabolic_diseases:_Single_institute_experience_Tokimasa S, Ohta H, Takizawa S, et al. 
Umbilical cord-blood transplantations from unrelated donors in patients with inherited metabolic diseases: Single-institute experience. [Journal Article]
Pediatr Transplant 2008 Sep; 12(6):672-6.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/18236395/full_citation/Potential_immunological_advantage_of_intravenous_mycophenolate_mofetil_with_tacrolimus_and_steroids_in_primary_deceased_donor_liver_transplantation_and_live_donor_liver_transplantation_without_antibody_induction_Jain A, Sharma R, Ryan C, et al. 
Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction. [JOURNAL ARTICLE]
Liver Transpl 2008 Jan 30; 14(2):202-209.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/16961749/full_citation/Review_article:_saving_the_colon_in_severe_colitis___the_case_for_medical_therapy_Travis S 
Review article: saving the colon in severe colitis - the case for medical therapy. [Journal Article]
Aliment Pharmacol Ther 2006 Oct.:68-73.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/16757439/full_citation/Stable_engraftment_after_a_conditioning_regimen_with_fludarabine_and_melphalan_for_bone_marrow_transplantation_from_an_unrelated_donor_Inamoto Y, Oba T, Miyamura K, et al. 
Stable engraftment after a conditioning regimen with fludarabine and melphalan for bone marrow transplantation from an unrelated donor. [Journal Article]
Int J Hematol 2006 May; 83(4):356-62.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/16443519/full_citation/Tacrolimus_and_mycophenolate_mofetil_after_nonmyeloablative_matched_sibling_donor_allogeneic_stem_cell_transplantations_conditioned_with_fludarabine_and_low_dose_total_body_irradiation_Nieto Y, Patton N, Hawkins T, et al. 
Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation. [Journal Article]
Biol Blood Marrow Transplant 2006 Feb; 12(2):217-25.
Abstract | Full Citation | Publisher Full Text | Find Related Articles